by Nick Nobel, University of Texas at Austin A microscopic image of remdesivir powder formulations after the thin-film freezing process. All formulations exhibited a brittle matrix structure of highly porous particles. Credit: University of Texas at Austin The only antiviral drug currently used to treat SARS-CoV-2, the coronavirus that causes COVID-19, is remdesivir, but administering...
An endogenous protein prevents the virus from fusing with host cells RUHR-UNIVERSITY BOCHUM STEPHANIE PFÄNDER IS LOOKING FOR GENES THAT INHIBIT CORONA VIRUSES. view more CREDIT: RUB, MARQUARD A protein produced by the human immune system can strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the...
by Peter Grad , Medical Xpress “This paper made my jaw drop.” “It is just a wacko hypothesis.” “This article isn’t so much a scientific paper as a representation of what a moron thinks a scientific paper is.” “You haven’t seen the stupidest published SARS-CoV-2 take yet [until you read this]. I PROMISE you.” The...
By Chris Smith @chris_writes Doctors in Spain think they found a new coronavirus symptom that can easily go undiagnosed even in hospitalized patients. A mouth rash, or enanthem, appeared in roughly 30% of a small cohort of confirmed COVID-19 patients who also displayed skin rashes. The CDC doesn’t list skin rashes of any kind on...
by Columbia University Irving Medical Center Cryo-EM reconstructions show how two different antibodies (blue) bind to the spike protein of the SARS-CoV-2 virus. Credit: David Ho / Columbia University Irving Medical Center Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in...
A single protein derived from a common strain of bacteria found in the soil will offer scientists a more precise way to edit RNA. The protein, called AcrVIA1, can halt the CRISPR-Cas13 editing process, according to new research from Cornell, Rockefeller University and the Memorial Sloan Kettering Cancer Center published in the journal Science. “We’re...
By HARRIET ALEXANDER FOR DAILYMAIL.COM Cholesterol-lowering drug Fenofibrate (Tricor) is providing a glimmer of hope Scientists in New York and Jerusalem believe the drug could help treat COVID The drug could reduce symptoms so that COVID-19 is no worse than a common cold, the study found Two scientists researching a potential treatment for coronavirus believe...
Researchers are scrambling to find other ways to diagnose the coronavirus and churn out millions of tests a week — a key step in returning to normality. The timing couldn’t have been worse. In March, just as Thailand’s coronavirus outbreak began to ramp up, three hospitals in Bangkok announced that they had suspended testing for...
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online in The New England Journal of Medicine. The ongoing Phase 1 trial is supported by the National Institute of Allergy...
By MARLENE LENTHANG FOR DAILYMAIL.COM he military’s number of coronavirus cases is rising at twice the national rate seeing a 33% spike from July 1 to 10 The national case growth rate was 16% for that same time period Since July 1 over 4,100 service members have tested positive for coronavirus In total there are...
